IMP3 expression in non-small cell lung cancer

Human Pathology

Volumn 40, Issue 8, 2009, Pages 1205-1206

  Bellezza, Guido ^a   Cavaliere, Antonio ^a   Sidoni, Angelo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

RNA BINDING PROTEIN; RNA BINDING PROTEIN IMP3; UNCLASSIFIED DRUG;

ADVANCED CANCER; CANCER RELAPSE; HIGH RISK PATIENT; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; LUNG ALVEOLUS CELL CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PROTEIN EXPRESSION; TISSUE MICROARRAY;

CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; NEOPLASM PROTEINS; RNA-BINDING PROTEINS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 67650447709     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2009.03.019     Document Type: Letter

References (5)

1. Li L., Xu H., Spaulding B.O., et al. Expression of RNA-binding protein IMP3 (KOC) in benign urothelium and urothelial tumors. Hum Pathol 39 (2008) 1205-1211
2. Nielsen J., Christiansen J., Lykke-Andersen J., Johnsen A.H., Wewer U.M., and Nielsen F.C. A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol Cell Biol 19 (1999) 1262-1270
3. Mueller-Pillash F., Lacher U., Wallrapp C., et al. Cloning a gene highly overexpressed in cancer coding for a novel KH-domain containing protein. Oncogene 14 (1997) 2729-2733
4. Xu H., Bourne P.A., Spaulding B.o., and Wang H.L. High-grade neuroendocrine carcinomas of the lung express K homology domain containing protein overexpressed in cancer but carcinoid tumors do not. Hum Pathol 38 (2007) 555-563
5. Kononen J., Bubendorf L., Kallioniemi A., et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4 (1998) 844-847